BTSG
HealthcareBrightSpring Health Services, Inc. Common Stock
Key Drivers
- Strong EBITDA
- Thin net margins
- High leverage
AIAI Summary
BrightSpring has shifted from a leverage‑constrained rollup to a cash‑generating platform with real deleveraging and M&A optionality, but the investment hinges on timely divestiture proceeds and sustained specialty pharmacy/adjusted‑EBITDA growth—watch for confirmed divestiture timing/size, two consecutive quarters of specialty script and EBITDA momentum, and a halt or offset of insider/KKR selling to validate the rerating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong EBITDA
- •Thin net margins
- •High leverage
BTSG delivers solid EBITDA and free cash flow but thin net margins, high leverage, large intangibles and limited cash leave solvency and valuation risks despite scale.
Price Behavior
Key Price Behavior Insights:
- •Flat last month
- •Buying at ~$38
- •Resistance near $44
Over the last month BTSG was essentially flat (~+0.4%), trading choppily between support near $38.31 and resistance near $43.98, indicating a neutral short-term trend with elevated volatility and reversal risk.
Sharp swing from $38.31 to $43.98 mid‑March indicates elevated short-term volatility
Sentiment & News
Key News Insights:
- •Earnings upside
- •Deleveraging plan
- •Institutional inflows
BrightSpring beat expectations, pushed bullish 2026 EBITDA guidance, signaled deleveraging with $2B M&A optionality, and attracted analyst upgrades and institutional buying.
Positive operational momentum and clearer capital allocation plans should support the stock's re-rating and near-term upside potential
Similar Companies in Healthcare
Other companies in the same sector with AI ratings